Looking for opportunities in the Chinese market at the CIIE | CIIE Observation

Economic Observer Follow 2026-11-10 10:59

As a "full-time student" of the CIIE, Klaus Maffei has signed multiple orders and connected with multiple new customer resources at the CIIE site in the past few years. At this year's CIIE, market opportunities continue to emerge. The company not only signed a deepening strategic cooperation agreement with Shanghai Box Intelligent Technology Co., Ltd., but also negotiated new cooperation with a petrochemical client.

In addition, Li Xinfeng, Chief Financial Officer of KraussMaffei China, observed that with the rapid development of new energy vehicles and low altitude economy in China, new application scenarios have brought more market demand and imagination space to the company. At this year's CIIE, Klaus Maffei's exhibition focused on three major directions: high-end automotive molding, cross-border innovative applications, and green intelligent manufacturing.

Li Xinfeng's feelings are not isolated cases. After nine consecutive years of hosting, the CIIE has become not only a global platform for launching new products and technologies, but also an important carrier for multinational enterprises to connect with the Chinese market and explore new opportunities. At this year's CIIE, several heads of multinational companies coincidentally mentioned in interviews that the fields of new energy and health are new growth opportunities in the Chinese market.

Public information shows that the cumulative intended transaction volume of the first eight CIIE has exceeded 500 billion US dollars, among which the intended transaction volume of the eighth CIIE (2025) reached 83.49 billion US dollars per year, setting a new historical high.

Opportunities for new energy vehicles

As a manufacturer of rubber production, processing machinery, and systems, Klaus Maffei has continuously expanded its technology research and business layout in the field of new energy vehicles in the past few years. At this year's CIIE, Klaus Maffei showcased multiple technologies related to the new energy vehicle business on site.

For example, as the patent holder of ColorForm in mold painting technology, Klaus Maffei highlighted this process on site. Simply put, ColorForm in mold painting technology was mainly used for automotive interior parts in the early days, which can achieve integrated molding of decoration and protection; In 2025, Klaus Maffei and Kurz will jointly develop the application of this technology in car lights, achieving high gloss, weather resistance, and chemical corrosion resistance surface effects.

Li Xinfeng stated that moving from interior parts to large-sized exterior parts is a crucial step in expanding the boundaries of this technology and a concentrated manifestation of multi-party collaboration in the industrial chain. In March of this year, KraussMaffei, together with industry chain partners such as Ideal Automobile and Fuwei Co., Ltd., held the first large-scale in mold spray coating exterior parts offline ceremony in China at the Jiaxing production base.

In addition, according to Li Xinfeng, Klaus Maffei is also promoting the research and application of a large-scale panoramic sunroof glass polyurethane coating production line for new energy vehicles, integrating processes such as glass edging, polyurethane foaming, automatic loading and unloading, and whole line control, to promote the systematic and intelligent upgrading of automotive parts manufacturing.

Li Xinfeng said, "The company will continue to explore new scenarios for adapting its own technology. The automotive industry is the core application area, and we will also continue to pay attention to medical, low altitude economy, and embodied intelligence, focusing on tackling technical difficulties and expanding application scenarios

In 1994, Atlas Copco, a multinational industrial group, established compressor production business in Wuxi. Since then, it has successively set up R&D centers and launched vacuum technology business in China. In 2025, on the basis of a slight decline in the overall revenue of the group, the Asian market, which accounts for about 36% of the group's total revenue, achieved rapid growth.

Le Anlan, vice president of Atlas Copco Greater China, observed that China is accelerating its transformation to a high-tech and high value-added industry. The transformation of the automobile industry from a traditional internal combustion engine to a new energy vehicle is a good case. The company has accumulated rich experience in the production of new energy vehicles, solar energy, and batteries, and has established cooperative relationships with these industries at an early stage. Therefore, we are confident that China will continue to be an important strategic market for technology development

Resolutely invest in the Chinese health market

In recent years, the health sector in China has received increasing market attention. Among the six exhibition areas of the 9th CIIE, the medical equipment and healthcare exhibition area set multiple records - the exhibition area had the largest exhibition space in previous CIIEs. Gathering 12 Fortune 500 pharmaceutical companies, with 16 of the top 20 global pharmaceutical companies participating in the exhibition; After the new policy of expanding the opening up of the field of wholly foreign-owned hospitals was promulgated, the first wholly foreign-owned tertiary comprehensive hospital in China made its debut at the CIIE.

Taking "Artificial Intelligence (AI)+Health" as an example, Liu Ling, a member of the Philips Global Executive Committee and President of Greater China, observed that China is actively promoting the integration of AI into medical practice and is the forefront market for global medical AI applications. The "Future Health Index Report" released by the company on the same day also showed that 87% of Chinese clinical healthcare workers surveyed stated that AI has improved workflow efficiency, higher than the global average of 71%. Over 80% of Chinese healthcare workers and patients surveyed believe that AI can help improve the supply of medical services in areas with insufficient medical resources and rural areas.

As a "full-time student" at the CIIE, Roche Pharmaceuticals showcased nearly a hundred exhibits at the event, including new products to be launched in China and future pipelines. Roche Pharmaceuticals also revealed on site that in the next 2 to 5 years, nearly 20 new products and over 40 new indications will be submitted for market application in China, covering multiple treatment fields such as oncology/hematology, neuroscience, immunology, and ophthalmology.

Roche Pharmaceuticals China President Bian Xin stated that in the future, Roche Pharmaceuticals will take the CIIE as an important pivot for open cooperation, continue to strengthen its local layout, deeply integrate into the Chinese medical innovation ecosystem, and fulfill its firm commitment to work together with all parties to build a healthy future.

To enrich the existing myopia management solutions, Zeiss released a new generation of ophthalmic endoscope product PTLUNANA at this year's CIIE, which was approved for market by the China National Medical Products Administration in September this year.

Fei Mingyuan, President and CEO of Zeiss Greater China, stated that China is not only Zeiss' largest single market globally, but also an important source of innovation. PTLUNANA is an innovative achievement that the company has rooted in China and incubated with local partners, which also confirms the company's long-term strategy in China to create lasting value through innovation.

In addition, the Global Development and Health Communication Research Center of the School of Journalism and Communication at Tsinghua University, in collaboration with Meituan Medical Health, has released the "Report on the Current Situation of Family Health Management in China and Innovative Practices of Digital Platforms". The report also shows that with the aging of the Chinese population, shrinking family sizes, cross residence living of family members, and increasing demand for chronic disease management, family health management is gradually shifting from single member medical affairs to continuous health management involving multiple members, multiple types of needs, and multiple service links.

Huan Shitong, Senior Advisor at the Global Development and Health Communication Research Center of Tsinghua University, stated that the health needs of Chinese families are becoming increasingly diverse. Although digitalization has expanded the channels for obtaining health information and remote assistance, home health management still faces practical challenges in terms of information acquisition, service acquisition, task connection, and time investment. The long-term management of chronic diseases and the supply-demand connection of women's health services are particularly noteworthy. In the future, family health management can start with scenario pilot projects, strengthen cooperation among multiple parties, promote effective connection of health services, and improve the level of family health management in China.


The journalist from the State owned Assets Supervision and Administration Commission focuses on macroeconomic and relevant industrial policies of the Ministry of Human Resources and Social Security. Proficient in detailed and in-depth writing.

Hot News

{"code":"1","message":"Request processing failed; nested exception is com.aebiz.b2b2c.ext.trans.BaiduTranslateUtil$TranslationException: 翻译失败: 翻译出错: auth open api usage limit reached"}